The Ophthalmic Pharmaceutical Drugs Market Is Expected

Raipur, Nov. 18, 2022 (GLOBE NEWSWIRE) — Stratview Research, a leader market research firm launched a report on Ophthalmic Pharmaceutical Drugs Market which provides in-depth analysis of market dynamics, current and emerging trends, industry forecasts and competitive landscape.

Click here to get the free sample pdf:

How is the report useful?

The report has great utility for key decision makers and strategists in terms of accurate market insights, future growth opportunities, and key success factors.

Most importantly, the report analyzes the possible impact of COVID-19 on the market dynamics, which provides cushion against the uncertain business environment and helps streamline resources and investment decisions fruitfully.

What are the main market drivers?

According to the report, the Ophthalmic Pharmaceutical Drugs Market is influenced by a host of factors, some of which are noted below:

  • The increasing prevalence of eye diseases such as glaucoma, cataracts and macular degeneration.
  • Rising geriatric population, growing demand for ophthalmic drugs and a surge in investment in R&D activities by various healthcare companies
  • Increased health care awareness to prevent the risk of eye diseases, increase in demand for ophthalmic drugs, and growing initiatives are taken by the government for the development and manufacture of different combination ophthalmic drugs.

The report also includes growth rate estimates based on the intensity of drivers and restraints and provides users with several graphical illustrations of key information.

Ophthalmic Pharmaceutical Drugs Market Segmentation:

Stratview Research has segmented the market in the following manner, which meets the market data needs of multiple stakeholders across the industry value chain.

  • By type (prescription drugs, over-the-counter drugs),
  • By class type (Antiallergic, Anti-VEGF Agents, Anti-inflammatory [Nonsteroidal Drugs, Steroidal Drugs]Antiglaucoma, Others),
  • By disease type (Dry eye, eye allergy, glaucoma, eye infection, retinal disorders [Macular Degeneration, Diabetic Retinopathy, Others]Uveitis, Others),
  • By dosage type (gels, eye solutions, capsules and tablets, eye drops, ointments),
  • By region (North America, Europe, Asia-Pacific and Rest of the World).

Ophthalmic Pharmaceutical Drugs Market Knowledge

Market trends by Type

The market has been segmented into (prescription drugs and over-the-counter drugs). The Prescription drugs segment represented a revenue share of nearly 60% in 2021.

Market trends by To classify Type

The ophthalmic pharmaceutical drugs market is categorized into antiallergics, anti-VEGF agents, anti-inflammatory antiglaucoma and others. The Anti-VEGF Agents segment represented a revenue share of more than 31.0% in 2021 and is estimated to register a healthy CAGR during the forecast period. This is mainly attributed to the growing adoption rate and the significant presence of global industry players with large product portfolios. Segment growth is driven by the strong commercial performance of Avastin (bevacizumab), Lucentis (ranibizumab) and Macugen (pegaptanib), which support segment growth.

Market trends by Sickness Type

The market has been segmented into (dry eye, eye allergy, glaucoma, eye infection, retinal disorders [Macular Degeneration, Diabetic Retinopathy, and Others], uveitis and others). The Retinal disorders segment represented a revenue share of more than 33.0% in 2021.

Market trends by Dosage Type

The market has been segmented into (Gels, Eye Solutions, Capsules & Tablets, Eye Drops and Ointments). The Eye drops segment represented a revenue share of more than 34.0% in 2021.

Which region offers the best opportunity and growth?

The North American market represented a revenue share of more than 39.5% in 2021 and is expected to grow at a substantial CAGR in the coming years. This is mainly attributed to an increase in the number of cataract surgeries performed, strong consumer awareness, presence of excellent healthcare infrastructure, significant presence of a majority of major players and an increase of government intervention for the prevention of visual impairment, which will proliferate the growth of the regional market.

Impact of COVID-19 on the Pharmaceutical Ophthalmic Drugs Market

COVID-19 has brought an instant halt to many industries around the world. Lockdown norms in several countries quickly affected the global economy by affecting supply chain, production and market demand. The direct and indirect impacts of the pandemic have been integrated into this report.

To learn more about the impact of covid-19, get a free sample report here:

Who are the best market players?

After in-depth analysis of the market, the experts have listed down few key players and discussed the company profiles of the players below –

  • AbbVie Inc. (Allergan plc) (USA)
  • Alcon Inc. (Switzerland)
  • Bausch & Lomb Incorporated (Canada)
  • F. Hoffmann-La Roche SA (Genentech, Inc.) (Switzerland)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (USA)
  • Regeneron Pharmaceuticals Inc.
  • Santen Pharmaceutical Co., Ltd. (Japan)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Teva Pharmaceutical Industries Ltd. (Actavis Generics) (Israel).

What deliverables will you get in this report?

  • In-depth analysis of the Ophthalmic Pharmaceutical Drugs Market
  • Detailed market segmentation.
  • Analysis of the competitive landscape.
  • Historical, current and future market size analysis.
  • Industry trends, technologies and advancements.
  • Growth and operating strategies adopted by key players.
  • Potential segments/regions offering promising growth.
  • Geographical presence of the main actors.

Related reports that might be helpful:

  1. Ophthalmic Instrumentation Market

  1. Dry Eye Market

About Us –

Stratview Research is a global market research company that offers reliable market reports, market entry strategies, strategic growth advice, and more. Market experts compile high-quality market information to help users gain granular level clarity on current business trends and expected future developments. Stratview Research also offers report customization. Contact the analysts to customize the given report according to your priority/requirement.

Stratview Research has also launched “composight”, an online portal that offers free thought leadership reports, white papers, market report summaries and more for the composites and related industries, worth $20,000 each year.

Click here to register (free of charge):